Table 3 Baseline characteristics of the study subjects in the XO quartiles.

Number (n)

81

81

82

81

–

Age (years)

39.1 ± 12.1 (71.0)

42.7 ± 12.7 (70.0)

46.1 ± 12.7 (85.0)

46.4 ± 12.0 (70.0)

0.000

Weight (kg)

67.9 ± 9.1 (92.0)

66.1 ± 10.6 (96.6)

65.9 ± 13.8 (105.0)

60.7 ± 11.0 (98.0)

0.000

Height (cm)

76.7 ± 81.7 (181.0)

107.6 ± 75.7 (178.0)

105.0 ± 77.2 (177.0)

81.4 ± 77.7 (175.0)

0.019

BMI (kg/m²)

25.2 ± 3.5 (38.0)

25.3 ± 3.6 (34.0)

25.3 ± 4.0 (40.0)

24.9 ± 3.9 (35.0)

0.901

WC (cm)

87.9 ± 8.9 (104.1)

88.6 ± 11.5 (116.0)

87.5 ± 10.0 (111.0)

83.3 ± 9.6 (111.0)

0.013

HC (cm)

94.1 ± 7.3 (108.0)

93.0 ± 9.1 (113.0)

91.5 ± 8.1 (110.0)

89.3 ± 7.1 (113.0)

0.008

SBP (mmHg)

121.6 ± 12.7 (160.0)

128.0 ± 16.5 (180.0)

134.6 ± 17.9 (216.0)

135.2 ± 19.7 (190.0)

0.000

DBP (mmHg)

82.8 ± 9.0 (112.0)

83.0 ± 9.6 (110.0)

85.3 ± 9.8 (110.0)

85.9 ± 10.3 (118.0)

0.097

PP (Beats/min)

75.4 ± 9.3 (96.0)

80.7 ± 12.3 (122.0)

81.4 ± 14.6 (124.0)

81.2 ± 10.9 (112.0)

0.008

FBG (mmol/L)

6.6 ± 4.1 (26.9)

7.9 ± 4.3 (20.3)

8.5 ± 4.2 (22.3)

9.6 ± 4.4 (24.9)

0.000

XO (U/L)

1.5 ± 0.6 (2.2)

2.9 ± 0.4 (3.7)

4.7 ± 0.7 (5.9)

9.0 ± 2.9 (18.9)

0.000

SUA (mg/dL)

6.1 ± 2.0 (12.9)

5.6 ± 2.2 (11.8)

5.5 ± 1.6 (9.2)

5.1 ± 2.0 (10.0)

0.022

Creatinine (mg/dL)

0.9 ± 0.4 (2.5)

0.9 ± 0.2 (1.5)

0.9 ± 0.3 (2.0)

0.8 ± 0.3 (2.1)

0.030

eGFR (mL/min/1.73 m²)

93.7 ± 19.2 (149.1)

92.5 ± 15.4 (126.2)

87.2 ± 21.2 (123.1)

84.2 ± 17.1 (116.8)

0.019

SA (g/L)

53.0 ± 14.1 (94.4)

44.7 ± 9.6 (70.6)

43.0 ± 7.7 (60.6)

40.7 ± 8.9 (54.4)

0.000

TG (mg/dL)

194.3 ± 121.9 (675.2)

182.8 ± 118.1 (583.3)

211.7 ± 126.7 (726.6)

219.4 ± 124.4 (812.6)

0.284

TC (mg/dL)

204.9 ± 66.3 (463.5)

237.2 ± 108.5 (562.8)

218.4 ± 89.6 (584.0)

219.2 ± 81.7 (469.8)

0.190

HDL (mg/dL)

31.4 ± 9.2 (63.2)

34.9 ± 13.2 (91.0)

36.5 ± 16.7 (112.4)

35.6 ± 12.9 (82.0)

0.112

LDL (mg/dL)

135.5 ± 63.5 (324.6)

167.6 ± 101.0 (517.2)

139.8 ± 79.4 (506.5)

141.5 ± 79.1 (368.3)

0.087